News Release icon Contact: Media Relations Office (518) 956-8150


RNA Researchers: Lighting the Way

ALBANY, N.Y. (November 30, 2015) — The challenge in harnessing the promise of RNA therapeutics is making RNA visible enough to be detected using fluorescent chemical tags. Scientists at The RNA Institute, with the help of industry partners, are busy creating this tagging technology.

BD (Becton, Dickinson and Company), one of the world’s leading medical technology companies, is supporting the pioneering efforts in this area of Maksim Royzen and Mehmet Yigit of the Department of Chemistry and the Institute. Using fluorescent imaging technologies, including a state-of-the-art fluorescence-activated cell sorter, Royzen and Yigit create fluorescent chemical tags that allow cells containing specific RNA, which are implicated in diseases such as cancer, to be sorted and studied.

The ultimate quest is to find new RNA-based therapies and an enhanced molecular understanding of RNA’s role in disease processes and normal cell changes, such as those occurring during development and aging.

RSS Link For more news, subscribe to UAlbany's RSS headline feeds

About the University at Albany
A comprehensive public research university, the University at Albany offers more than
120 undergraduate majors and minors and 125 master's, doctoral, and graduate certificate programs. UAlbany is a leader among all New York State colleges and universities in such diverse fields as atmospheric and environmental sciences, business, criminal justice, emergency preparedness, engineering and applied sciences, informatics, public administration, social welfare, and sociology taught by an extensive roster of faculty experts. It also offers expanded academic and research opportunities for students through an affiliation with Albany Law School. With a curriculum enhanced by 600 study-abroad opportunities, UAlbany launches great careers.